Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals (United States)

Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

66


Total Open
Publications

42


Total
Citations

2.6K


Open Access
Percentage

64%


Total
Publications

66


Total Open
Publications

42


Total
Citations

2.6K

Wikipedia

Website

download

Breakdown

20% 32% 12% 36%

Publisher Open

20%

Both

32%

Other Platform Open

12%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

7

Hybrid 62%

21

No Guarantees 18%

6

Other Platform Open

Domain 83%

24

Preprint 17%

5

Institution 14%

4

Public 14%

4

Other Internet 7%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
24
Europe PMC
Domain
14
bioRxiv
Preprint
4
University of California - eScholarship University of California
Institution
3
Semantic Scholar
Public
3
DOI
Other Internet
2
RePEc: Research Papers in Economics - RePEc
Preprint
1
Imperial College London - Spiral
Institution
1
Figshare
Public
1
1 / 1

Data updated 17 June 2024

Share

Share

Share